Masson Research Group

The joint lab HitCat was officialized in June 2021 and is going to take flight. It was born from the rapprochement between SEQENS - a company specialized in pharmaceutical synthesis and in speciality ingredients - and the CNRS.

This laboratory, under the conjoint scientific direction of Dr. Géraldine Masson (CNRS Research Director at ICSN) and Dr. Gérard Guillamot (SEQENS Scientific Director), aims to create a Centre d'excellence (Excellence Center) i,n multicatalysis as well as in high throughput  catalytical evaluation.